<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H618FCA0258BE4215AE839003B6EB235D" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 238 IH: Residential Substance Use Disorder Treatment Act of 2023</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-01-10</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 238</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230110">January 10, 2023</action-date><action-desc><sponsor name-id="J000032">Ms. Jackson Lee</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HJU00">Committee on the Judiciary</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Omnibus Crime Control and Safe Streets Act of 1968 to reauthorize the residential substance use disorder treatment program, and for other purposes.</official-title></form><legis-body id="HB462A4500B0C404583CBB033BB62F154" style="OLC"> 
<section section-type="section-one" id="H95888E21DEC848C79C646148F2809ADD"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Residential Substance Use Disorder Treatment Act of 2023</short-title></quote>.</text></section> <section id="H653EC9A9F2F34F1D91EFC7832654A453"><enum>2.</enum><header>Residential substance use disorder treatment program</header> <subsection id="HE5A285495B62442FA3A23A236EB50C35"><enum>(a)</enum><header>Amendments</header><text>Part S of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (<external-xref legal-doc="usc" parsable-cite="usc/34/10421">34 U.S.C. 10421 et seq.</external-xref>) is amended—</text> 
<paragraph id="H55BC1BD41FBA47B1B89EAE0E1030C42A"><enum>(1)</enum><text>in the part heading, by striking <quote><header-in-text style="OLC" level="part">substance abuse</header-in-text></quote> and inserting <quote><header-in-text style="OLC" level="part">substance use disorder</header-in-text></quote>;</text></paragraph> <paragraph id="HD30EED1FE50F4AB598D9748677574C4E"><enum>(2)</enum><text>in section 1901 (<external-xref legal-doc="usc" parsable-cite="usc/34/10421">34 U.S.C. 10421</external-xref>)—</text> 
<subparagraph id="HEF17DE98111C4F8FB1A168EF2F2F7036"><enum>(A)</enum><text>in subsection (a)—</text> <clause id="H2EB0E8AC38CE4E568A0197D71AA74F8E"><enum>(i)</enum><text>in paragraph (1)—</text> 
<subclause id="H23A842ED43AE4D06BCB490513D63D54D"><enum>(I)</enum><text>by striking <quote>substance abuse</quote> each place it appears and inserting <quote>substance use disorder</quote>; and</text></subclause> <subclause id="H5053640894094D30BB9CC91949C18425"><enum>(II)</enum><text>by inserting after <quote>programs</quote> the following: <quote>, including medication-assisted treatment programs, which shall be permitted to use any type of medication that has been approved to treat substance use disorders pursuant to section 505 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355">21 U.S.C. 355</external-xref>), or any type of biological product licensed under section 351 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/262">42 U.S.C. 262</external-xref>),</quote>; and</text></subclause></clause> 
<clause id="HCDEAB964943F4BA8B3935FFC950597A0"><enum>(ii)</enum><text>in paragraph (3), by striking <quote>substance abuse</quote> each place it appears and inserting <quote>substance use disorder</quote>;</text></clause></subparagraph> <subparagraph id="HFA759DDA444D4BE692F9B4A89A902811"><enum>(B)</enum><text>in subsection (b), by striking <quote>substance abuse</quote> and inserting <quote>substance use disorder</quote>; and</text></subparagraph> 
<subparagraph id="H083C583BEF124F56B4CA4A4863D248A2"><enum>(C)</enum><text>in subsection (c)—</text> <clause id="HDFB9C44A1DB34E64A7BDAB7F6B13A008"><enum>(i)</enum><text>by striking <quote>part for treatment</quote> and inserting “part for—</text> 
<quoted-block style="OLC" display-inline="no-display-inline" id="H94227CC599A64B1D8B99AE682189E2EB"> 
<paragraph id="H0A1EC79995204A3EBCEF752F7168A821"><enum>(1)</enum><text>treatment</text></paragraph><after-quoted-block>;</after-quoted-block></quoted-block></clause> <clause id="HCF953A2B66F5400F9BC29F2B0C2BA052"><enum>(ii)</enum><text>in paragraph (1), as so designated, by striking the period at the end and inserting <quote>; and</quote>; and</text></clause> 
<clause id="HC530DE9C2314474A847DAE78C5C2C9BC"><enum>(iii)</enum><text>by adding at the end the following:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="H7E2D4DC4F91444CF843D4233B6EA4DAF"> <paragraph id="HFE5FB7CDA4DE4D3382B4AAC45110E246"><enum>(2)</enum><text>expanding residential substance use disorder treatment programs to use not less than 1 medication or treatment that has been approved to treat substance use disorders pursuant to section 505 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355">21 U.S.C. 355</external-xref>).</text></paragraph><after-quoted-block>;</after-quoted-block></quoted-block></clause></subparagraph></paragraph> 
<paragraph id="H2B84BA47D4B44519B23D8CEFB601BFD8"><enum>(3)</enum><text>in section 1902 (<external-xref legal-doc="usc" parsable-cite="usc/34/10422">34 U.S.C. 10422</external-xref>)—</text> <subparagraph id="H5A351042F1374C46A4134AA90D268E64"><enum>(A)</enum><text>in subsection (b)—</text> 
<clause id="HEEACB7134A6B4244B079C3A9D5E78D65"><enum>(i)</enum><text>in the subsection heading, by striking <quote><header-in-text style="OLC" level="subsection">abuse</header-in-text></quote> and inserting <quote><header-in-text style="OLC" level="subsection">use</header-in-text></quote>; and</text></clause> <clause id="H906069626DD04ACAA30EE812843B65DF"><enum>(ii)</enum><text>by striking <quote>substance abuse</quote> each place it appears and inserting <quote>substance use disorder</quote>;</text></clause></subparagraph> 
<subparagraph id="H9739C05FDFDD40419584E50BF2A1F4A2"><enum>(B)</enum><text>in subsection (c), by striking <quote>substance abuse</quote> each place it appears and inserting <quote>substance use disorder</quote>;</text></subparagraph> <subparagraph id="H3305B36DF2744376942218FF80E8ABFB"><enum>(C)</enum><text>in subsection (d), by striking <quote>substance abuse treatment</quote> and inserting <quote>substance use disorder treatment</quote>;</text></subparagraph> 
<subparagraph id="HE6FC4F84892A40BDAD3652333532E10E"><enum>(D)</enum><text>in subsection (f), by striking <quote>substance abuse</quote> and inserting <quote>substance use disorder</quote>; and</text></subparagraph> <subparagraph id="H4CFB453718564E119E49478BBE31EA96"><enum>(E)</enum><text>by adding at the end the following:</text> 
<quoted-block style="OLC" display-inline="no-display-inline" id="HFD7E0AF75CDB4D379295AF1284CE5732"> 
<subsection id="H0DEB80D242CA4E2992498C16325CE788"><enum>(g)</enum><header>Training requirement</header> 
<paragraph id="H5BA260ABBAF046C593B363344589C7F5"><enum>(1)</enum><header>In general</header><text>To be eligible to receive funds under this part, the chief medical officer of the prison or jail or appropriate staff overseeing the program shall complete training, before or within a reasonable amount of time after receiving the funds, on, at a minimum—</text> <subparagraph id="H9D2A3C6EC8C74F939B39BDDD2429E2CD"><enum>(A)</enum><text>the science of addiction;</text></subparagraph> 
<subparagraph id="H477B920B1E6A4F6DAE49134F4A1FE44C"><enum>(B)</enum><text>the latest research and clinical guidance for detoxification and withdrawal management and the treatment of substance use disorders in criminal justice settings;</text></subparagraph> <subparagraph id="H9CDB8EE2543445E586A881389D36615B"><enum>(C)</enum><text>strategies for continuity of care during and after incarceration; </text></subparagraph> 
<subparagraph id="H5F0C7605B7F343F9A791465BC1D09952"><enum>(D)</enum><text>an overview of—</text> <clause id="H5B6A242E74C941769FB72F753FC25DFD"><enum>(i)</enum><text>all medications for the treatment of substance use disorders;</text></clause> 
<clause id="H715CEA090EBB48DEB1924866751A01D0"><enum>(ii)</enum><text>how to obtain certification as an opioid treatment provider (OTP) or waivers under the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/801">21 U.S.C. 801 et seq.</external-xref>) for prescribing certain medications; and</text></clause> <clause id="H6E6D8A3268FD419FB51D717C212548AC"><enum>(iii)</enum><text>evidence-based behavioral therapies used in addition to medication to improve medication adherence and treatment outcomes; and</text></clause></subparagraph> 
<subparagraph id="HE72FBC628BC441A0864263F72C733108"><enum>(E)</enum><text>any other topic determined by the Attorney General, in coordination with the Secretary of Health and Human Services and in consultation with experts in addiction science, to be a core element for successful training under this paragraph. </text></subparagraph></paragraph> <paragraph id="HD406D9E6A81541BCA138218F17E1FA1A"><enum>(2)</enum><header>Requirement</header><text>The training required under paragraph (1) shall include guidance on how to—</text> 
<subparagraph id="H999211BE434B4E0CBD814921DD883264"><enum>(A)</enum><text>engage relevant stakeholders;</text></subparagraph> <subparagraph id="HE479631C178D495FBD0270CF352880A5"><enum>(B)</enum><text>identify available resources for, and gaps and barriers to, providing residential substance use disorder treatment; and</text></subparagraph> 
<subparagraph id="HEFA73A3080564CC4BC29F6182BFB16E0"><enum>(C)</enum><text>develop a plan to overcome obstacles to administering and offering medication-assisted treatment.</text></subparagraph></paragraph></subsection> <subsection id="H05EA39362FF240BB8688F197E0E64A9A"><enum>(h)</enum><header>Provider affiliation</header><text>Any entity, including a prison or jail, that receives Federal funds for a program or activity that offers medication-assisted treatment shall have an affiliation with a provider that can— </text> 
<paragraph id="H265512C23A1A4BCB91A896E594EDBAD0"><enum>(1)</enum><text>prescribe not less than 1 medication-assisted treatment to patients after release from the entity; and</text></paragraph> <paragraph id="H2324F53A2D9C415E9B45FF28EED4F722"><enum>(2)</enum><text>discuss the risks and benefits of, and alternatives to, medication-assisted treatment with patients.</text></paragraph></subsection><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph></paragraph> 
<paragraph id="HFAB89D0A00FE4FA8BBE3457EF72DA77F"><enum>(4)</enum><text>in section 1904 (<external-xref legal-doc="usc" parsable-cite="usc/34/10424">34 U.S.C. 10424</external-xref>)—</text> <subparagraph id="H5BD5D4A31ECB47D5AC08494A7110B3F9"><enum>(A)</enum><text>by amending subsection (c) to read as follows:</text> 
<quoted-block style="OLC" display-inline="no-display-inline" id="H186D1F35DFD74D2FA8CA0036C3DAC891"> 
<subsection id="HE65E7EA82FAA47C299EC179F392C3CE6"><enum>(c)</enum><header>Local allocation</header> 
<paragraph id="H6BBDB9D162F840398FC8D62E509ADD0B"><enum>(1)</enum><header>In general</header><text>Not less than 10 percent of the total amount made available to a State under subsection (a) for any fiscal year shall be used by the State to make grants to local correctional and detention facilities in the State (provided such facilities exist therein).</text></paragraph> <paragraph id="H2E57A82C193443BDA4C38B0A1630BCE6"><enum>(2)</enum><header>Jail-based substance use treatment programs</header><text>A jail-based substance use disorder treatment program described in paragraph (1) may be made available to any individual who is—</text> 
<subparagraph id="H907F35A7524D4C1FA3D7B338253FED89"><enum>(A)</enum><text>awaiting trial or is otherwise in pre-trial detention; or</text></subparagraph> <subparagraph id="H8C80C683F35C4C5C96E7901F729C75F3"><enum>(B)</enum><text>serving a sentence of imprisonment in the jail.</text></subparagraph></paragraph></subsection><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph> 
<subparagraph id="HA080A53CB0C2421F96DC96B740C676BD"><enum>(B)</enum><text>by amending subsection (d) to read as follows:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="H70415A83640441A48A4654A98D384762"> <subsection id="HE48830C4B584479783474F8C7B952A08"><enum>(d)</enum><header>Evidence-Based treatments</header> <paragraph id="H4521F704620E4DDBA51E622C13C757F1"><enum>(1)</enum><header>In general</header><text>A State may use amounts received under this part to—</text> 
<subparagraph id="H19F85E358A66458D886F59D1105FBF48"><enum>(A)</enum><text>provide any type of medication-assisted treatment that has been approved to treat substance use disorders pursuant to section 505 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355">21 U.S.C. 355</external-xref>), and any type of biological product licensed under section 351 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/262">42 U.S.C. 262</external-xref>), and prescribe overdose reversal medications during the residential substance use disorder treatment program or after care;</text></subparagraph> <subparagraph id="H96B3DA05476F4E7C8C9921442D5143E2"><enum>(B)</enum><text>cover costs associated with the training required under section 1902(g); </text></subparagraph> 
<subparagraph id="HD873793321BD43279B972E40C924EB06"><enum>(C)</enum><text>obtain waivers under clause (ii) or (iv) of section 303(g)(2)(G) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/823">21 U.S.C. 823(g)(2)(G)</external-xref>); and</text></subparagraph> <subparagraph id="HF0B987836CFE4D74917F3EB8BF246A21"><enum>(D)</enum><text>obtain certification as an opioid treatment provider (OTP) in accordance with part 8 of title 42, Code of Federal Regulations, or any successor thereto, or the prescription of medications to treat substance use disorders. </text></subparagraph></paragraph> 
<paragraph id="HD9A391968BCE4683A2C2A17BB458EF0A"><enum>(2)</enum><header>Definition</header><text>In this subsection, the term <term>medication-assisted treatment</term> means a treatment plan that combines behavioral therapy with any type of medication that has been approved to treat substance use disorders pursuant to section 505 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355">21 U.S.C. 355</external-xref>), or any type of biological product licensed under section 351 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/262">42 U.S.C. 262</external-xref>).</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph></subsection> <subsection id="H043294D015AE48FB8F2FBC5B19387700"><enum>(b)</enum><header>Authorization of appropriations</header><text>Section 1001(a)(17) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (<external-xref legal-doc="usc" parsable-cite="usc/34/10261">34 U.S.C. 10261(a)(17)</external-xref>) is amended to read as follows:</text> 
<quoted-block style="OLC" display-inline="no-display-inline" id="HB432FE9B7DF143B5B773B5D70B814BAF"> 
<paragraph id="H55FA3E5651914BB5B6FE74336F60F75D" indent="up1"><enum>(17)</enum><text>There are authorized to be appropriated to carry out the projects under part S $40,000,000 for each of fiscal years 2023 through 2027.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection> <subsection id="H8F7DDDC88A634285B6DF50CF81A86BD0"><enum>(c)</enum><header>Definition</header><text>Section 901(25) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (<external-xref legal-doc="usc" parsable-cite="usc/34/10251">34 U.S.C. 10251(25)</external-xref>) is amended to read as follows:</text> 
<quoted-block style="OLC" display-inline="no-display-inline" id="H70C440594F3442D6B5A790B93F3E9D00"> 
<paragraph id="H1C72EC04D4C34C129F9A8DB5B694E8B4"><enum>(25)</enum><text>the term <term>residential substance use disorder treatment program</term> means a course of comprehensive individual and group substance use disorder treatment services in residential treatment facilities that, to the greatest extent practicable, follow the guidance entitled, <quote>Promising Practice Guidelines for Residential Substance Abuse Treatment</quote>, published in November 2017 by the Bureau of Justice Assistance, or as thereafter amended to conform to current standards of care;</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section> </legis-body></bill>

